News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Analyst recommends buying Oracle common at $128 with a $115 stop and $160 target over about 45 trading days.
  • Oracle preferred shares, if available below $180, may offer superior risk/reward to common shares.
  • TOP Financial completed a cashless warrant exercise, issuing roughly 360.5 million restricted Class A shares and canceling remaining warrants.
  • TOP Financial's new shares are subject to a six-month lock-up.
  • Brookfield plans to combine its renewable and infrastructure dual-listed entities into single US-traded companies to boost liquidity and index inclusion, targeting Q4 2026.

Latest Articles

Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation

Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation

Cadrenal Therapeutics has aligned its cardiac critical care portfolio into a focused franchise and initiated partnering discussions for its late-stage assets including CAD-1005, frunexian, and tecarfarin. Promising Phase 2 data for CAD-1005 indicated a significant reduction in thrombotic events, bolstering the company’s strategy to leverage partner…

CVG Announces Second Quarter 2026 Earnings Call

CVG Announces Second Quarter 2026 Earnings Call

Commercial Vehicle Group, Inc. (NASDAQ: CVGI) announced its quarterly earnings conference call to discuss second quarter 2026 financial results, scheduled for August 4, 2026. The company will release a press release and presentation prior to the call. CVGI is a global provider of systems, assemblies, and components to commercial vehicle and electri…

Genius Group Launches Full AI-Powered Product Suite, Building on 147% Year-on-Year Revenue Growth in H1 2026.

Genius Group Launches Full AI-Powered Product Suite, Building on 147% Year-on-Year Revenue Growth in H1 2026.

Genius Group Limited (NYSE: GNS), a global AI-powered education company, has launched Genius OS, a full suite of AI agent-driven products integrating education, acceleration, and productivity solutions across K-12 school systems, entrepreneur and investor academies, and innovative community models. Building on robust growth with 147% year-on-year r…

Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule

Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule

Helus Pharma has completed enrollment ahead of schedule in its pivotal Phase 3 APPROACH study evaluating HLP003 as an adjunctive treatment for major depressive disorder (MDD). The completion marks a significant milestone for the company, with topline data expected in Q4 2026. HLP003 has received FDA Breakthrough Therapy Designation and showed promi…

ZenaTech's ZenaDrone Subsidiary Begins Scheduling U.S. Government Defense Demonstrations, Starting with First Confirmed Agency Engagement

ZenaTech's ZenaDrone Subsidiary Begins Scheduling U.S. Government Defense Demonstrations, Starting with First Confirmed Agency Engagement

ZenaTech's U.S.-based subsidiary ZenaDrone is initiating technology demonstrations with U.S. government defense agencies to transition its drone portfolio from testing to market readiness. Starting with the IQ Nano indoor drone, these demo engagements position ZenaDrone for future defense pilot programs and procurement opportunities. The company is…

ParaZero Receives Follow-On Order for Operational System Protecting High-Value Assets and Critical Infrastructure

ParaZero Receives Follow-On Order for Operational System Protecting High-Value Assets and Critical Infrastructure

ParaZero Technologies Ltd., a US-listed aerospace defense company, announced a follow-on order for its DefendAir Pods to be integrated within an autonomous Counter-UAS operational system. The DefendAir Pods provide a non-explosive, net-based solution to neutralize hostile drones, addressing rising threats to high-value assets and critical infrastru…

Rezolute to Participate in the BTIG Virtual Biotechnology Conference

Rezolute to Participate in the BTIG Virtual Biotechnology Conference

Rezolute, Inc., a late-stage rare disease biopharmaceutical company focused on refractory hypoglycemia treatments, announced that its management will participate in the BTIG Virtual Biotechnology Conference on July 28-29, 2026, holding one-on-one meetings with investors. The company highlights its antibody therapy ersodetug in clinical trials for h…

Arq Schedules Second Quarter 2026 Earnings Conference Call

Arq Schedules Second Quarter 2026 Earnings Conference Call

Arq, Inc., a NASDAQ-listed environmental technology company specializing in activated carbon products, will announce its Q2 2026 financial results on August 10, 2026, followed by a conference call on August 11. The company provides sustainable purification solutions and is the only vertically integrated producer of activated carbon products in Nort…

PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada

PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada

PolyPid Ltd. announced an exclusive commercial partnership with Azurity Pharmaceuticals to commercialize their lead product candidate, D-PLEX100, in the U.S. and Canada for preventing surgical site infections. The deal includes an upfront payment of $30 million and potential milestone payments exceeding $300 million, along with tiered royalties. Th…

Dragonfly Energy Appoints Transportation Industry Veteran Robert Keller to Lead National Fleet Sales

Dragonfly Energy Appoints Transportation Industry Veteran Robert Keller to Lead National Fleet Sales

Dragonfly Energy Holdings Corp. announced the appointment of Robert Keller as Director of National Fleet Sales. Keller brings nearly 40 years of experience in fleet operations and commercial vehicle sales, aiming to expand Dragonfly Energy's battery and power system technologies within the heavy-duty trucking market. The move enhances the company’s…

Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Plus Therapeutics announced a regional agreement with Medical Mutual to provide coverage for its CNSide® Cerebrospinal Fluid Tumor Cell Enumeration assay in Ohio and Kentucky, expanding contracted coverage to approximately 127 million people. The CNSide® CSF assay supports rapid diagnosis and treatment monitoring for patients with leptomeningeal me…

Cronos’ SOURZ by Spinach® Expands its Lineup of Edibles

Cronos’ SOURZ by Spinach® Expands its Lineup of Edibles

Cronos Group Inc., a leading global cannabis company, announced the expansion of its SOURZ by Spinach® Fully Blasted edible multipacks to include new flavors and rare cannabinoid blends. The new offerings aim to capitalize on Canada's top-selling edibles brand during the summer season, with availability across multiple provinces. This strategic pro…

FreightCar America, Inc. Continues Aftermarket Expansion with Acquisition of Leading Regional Distributor

FreightCar America, Inc. Continues Aftermarket Expansion with Acquisition of Leading Regional Distributor

FreightCar America, a leading U.S. manufacturer and supplier of railroad freight cars and components, has completed the acquisition of Southern Parts & Equipment, a distributor of new, used, and reconditioned railcar parts. This marks the company's second acquisition in the aftermarket space within a year, enhancing its distribution capabilities an…

Streamex Corp. Announces GLDY Now Available for Custody by Inspira Financial, Unlocking Yield-Bearing Gold Exposure for Traditional Finance Investors

Streamex Corp. Announces GLDY Now Available for Custody by Inspira Financial, Unlocking Yield-Bearing Gold Exposure for Traditional Finance Investors

Streamex Corp. announces that its gold-backed, yield-bearing asset GLDY Class B shares are now available for custody by Inspira Financial, a major qualified custodian with $63 billion in assets under management. This integration enables institutional investors, wealth managers, and advisors to access GLDY through familiar custody and account struct…

United Community Banks, Inc. Reports Second Quarter Earnings

United Community Banks, Inc. Reports Second Quarter Earnings

United Community Banks, Inc. reported robust second quarter 2026 earnings driven by 6.8% annualized loan growth, a sixth consecutive quarter of net interest margin expansion, and strategic corporate actions including the acquisition of Peach State Bank and the planned sale of Navitas equipment finance business. GAAP EPS rose to $0.95, up 51% year-o…

Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million

Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million

Jupiter Neurosciences announced a definitive license agreement to acquire perpetual exclusive U.S. rights to ALA-002, a patented non-racemic MDMA formulation with FDA Novel Chemical Entity designation, for up to $100 million in milestones and royalties. This acquisition diversifies Jupiter's clinical-stage CNS asset portfolio by adding a novel psyc…